2020
DOI: 10.12779/dnd.2020.19.4.152
|View full text |Cite
|
Sign up to set email alerts
|

Vulnerable Strata to Non-Adherence and Overuse in Treatment for Patients with Cognitive Impairment

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2022
2022
2022
2022

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
(1 citation statement)
references
References 21 publications
0
1
0
Order By: Relevance
“…However, in South Korea, the medicines for cognitive impairment—such as choline alfoscerate and L-carnitine—are covered by insurance through the NHIS. The over-prescription of these drugs has led to the deterioration of health insurance finances, and poses health risks to patients taking multiple drugs 62 , 63 . As a result, the cost burden on patients appears to have increased.…”
Section: Discussionmentioning
confidence: 99%
“…However, in South Korea, the medicines for cognitive impairment—such as choline alfoscerate and L-carnitine—are covered by insurance through the NHIS. The over-prescription of these drugs has led to the deterioration of health insurance finances, and poses health risks to patients taking multiple drugs 62 , 63 . As a result, the cost burden on patients appears to have increased.…”
Section: Discussionmentioning
confidence: 99%